AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
Adults laugh about 14 times, kids 140
Improves mitochondrial function
GLP-1s and BPC-157: tirzepatide, semaglutide, retatrutide, BPC-157 Follow the standard rules
Day 1: 500mg NAD IV (1.5-3hrs) Day 4: 100mg NAD SQ Day 6: 100mg NAD SQ Daily: 250mg NR/NMN in the morning Week 7 We round off our loading phase with a large IV dose of NAD+, getting your body to optimal levels that we maintain throughout the rest of the cycle
Research indicates that up to 50% of individuals may require a customized, more frequent injection schedule (such as every 2 to 4 weeks) to remain completely free of symptoms [2]